Literature DB >> 15589311

The eye in systemic inflammatory diseases.

Peter McCluskey1, Richard J Powell.   

Abstract

Systemic inflammatory diseases commonly affect the sclera, cornea, retina, and orbit, and can pose a serious threat to sight. They encompass both primary and secondary vasculitic disorders and specific granulomatous inflammatory conditions. As well as direct eye involvement from the systemic inflammatory process, there can be signs of ocular ischaemia due to carotid or ophthalmic arteritis, hypertensive retinopathy, and ocular complications such as chloroquine maculopathy related to anti-inflammatory drug treatment. Additionally, systemic infection relating to the eye, either as the result of primary infective disease processes or infection secondary to immunosuppression, might be mistaken as endogenous intraocular inflammation. Infection can closely mimic the ocular signs of endogenous inflammation, and in selected patients (such as those who have been immunosuppressed to treat vasculitis and who additionally have had invasive surgery, indwelling intravenous catheters, or systemic sepsis), it might be necessary to specifically exclude infection by the sampling and culturing of intraocular fluids and tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589311     DOI: 10.1016/S0140-6736(04)17554-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

Review 1.  Orbital and anterior visual pathway infection and inflammation.

Authors:  Roel De Wyngaert; Ingele Casteels; Philippe Demaerel
Journal:  Neuroradiology       Date:  2009-02-17       Impact factor: 2.804

Review 2.  [Inflammatory diseases of the orbit].

Authors:  A Zimmer; W Reith
Journal:  Radiologe       Date:  2008-12       Impact factor: 0.635

Review 3.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

Review 4.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  [Glucocorticoids: importance in the treatment of vasculitis].

Authors:  P M Aries; B Hellmich; W L Gross
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

6.  The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.

Authors:  Galina Dvoriantchikova; Eleut Hernandez; Jeff Grant; Andrea Rachelle C Santos; Huan Yang; Dmitry Ivanov
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

7.  Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial.

Authors:  Rongxin Chen; Guofu Huang; Shu Liu; Wenfang Ma; Xiaofang Yin; Shiyou Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-20       Impact factor: 3.117

Review 8.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 9.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

Review 10.  Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature.

Authors:  Sepideh Faez; Ann-Marie Lobo; Sebastian H Unizony; John H Stone; George N Papaliodis; Lucia Sobrin
Journal:  Clin Rheumatol       Date:  2014-04-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.